Funding for this research was provided by:
UK Research and Innovation (CV220-009)
NIHR ARC West (P512)
NIHR HPRU in Behavioural Science and Evaluation (P512)
Received: 10 March 2021
Accepted: 11 March 2021
First Online: 9 April 2021
: Provisional ethics approval was originally obtained from the NHS Health Research Authority, Yorkshire & The Humber - Leeds West Research Ethics Committee (20/YH/0261) on 14 August 2020, followed by full approval on 2 September 2020.Practices which support the study by promoting the Germ Defence website will, in doing so, have been deemed to have given implicit consent to participate. We will not be seeking individual patent consent as the study requires no deviation from usual care and clinical outcomes will be assessed from anonymised routinely collected NHS patient record data.
: Not applicable.
: The authors declare that they have no competing interests.